Protease stabilized acylated insulin analogues

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10259856
APP PUB NO 20150210748A1
SERIAL NO

14686176

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK A/SNOVO ALLE BAGSVAERD DK-2880

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Garibay, Patrick William Holte, DK 49 812
Glendorf, Tine Lyngby, DK 10 62
Hoeg-Jensen, Thomas Klampenborg, DK 50 369
Jakobsen, Palle Vaerloese, DK 54 446
Kjeldsen, Thomas Boerglum Virum, DK 24 85
Kodra, Janos Tibor Koebenhavn, DK 48 1333
Madsen, Peter Bagsvaerd, DK 117 1108
Petersen, Jacob Sten Charlottenlund, DK 11 119
Tagmose, Tina Moeller Ballerup, DK 17 88

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 16, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 16, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00